The Melanoma Research Alliance (MRA) is pleased to announce a Second Release of its Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, staging, and treatment.
The 2020 – 2021 award cycle, is anticipated to support at least $7.6 million in new funding. Proposals will be accepted for Established Investigator, Academic-Industry Partnership, Young Investigator, and Pilot Awards. Other Special Opportunities include awards focused on Immunotherapy, Radiation Oncology, Pediatric Melanoma, and for researchers in the UK and Israel.
• October 21, 2020: Young Investigator Award Eligibility Checklist Due
• November 4, 2020: Full Proposals Due for all Award Mechanisms
All proposals are due by 5:00 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL online application tool: https://proposalcentral.com/.
URL for more information:
Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found on the MRA website at CureMelanoma.org/RFP
Filed Under: Funding Opportunities